Page last updated: 2024-12-08

6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-(N-(4-aminobutyl)-N-ethyl)amino-2,3-dihydrophthalazine-1,4-dione: forms a conjugate with progesterone; conjugate used for immunoassay of plasma progesterone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID196441
CHEBI ID189286
SCHEMBL ID437558
MeSH IDM0099932

Synonyms (31)

Synonym
STK722002
6-[(4-aminobutyl)(ethyl)amino]-2,3-dihydrophthalazine-1,4-dione
abei
n-(4-aminobutyl)-n-ethylisoluminol, >=90%
n-(4-aminobutyl)-n-ethylisoluminol
66612-29-1
6-[n-(4-aminobutyl)-n-ethylamino]-2,3-dihydro-1,4-phthalazinedione
CHEBI:189286
6-[4-aminobutyl(ethyl)amino]-2,3-dihydrophthalazine-1,4-dione
A835504
AKOS005172582
FT-0641080
1,4-phthalazinedione, 6-((4-aminobutyl)ethylamino)-2,3-dihydro-
6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione
FT-0629202
SCHEMBL437558
AM83808
6-((4-aminobutyl)(ethyl)amino)-2,3-dihydrophthalazine-1,4-dione
6-[(4-aminobutyl)(ethyl)amino]-2,3-dihydro-1,4-phthalazinedione
AC-33251
DTXSID60216781
SR-01000108578-1
sr-01000108578
mfcd00010559
n-(4-aminobutyl)-n-ethylisolumiol
AS-61770
6-[(4-aminobutyl)(ethyl)amino]-1,2,3,4-tetrahydrophthalazine-1,4-dione
CS-0015212
LEOJISUPFSWNMA-UHFFFAOYSA-N
HY-D0890
SY051843
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phthalazines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (15.56)18.7374
1990's2 (4.44)18.2507
2000's6 (13.33)29.6817
2010's25 (55.56)24.3611
2020's5 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.27 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]